{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:21:10Z","timestamp":1773080470699,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Peking Union Medical College Fund-Rui E (Rui Yi) Emergency Medicine Research Special Fund","award":["22322012019"],"award-info":[{"award-number":["22322012019"]}]},{"name":"the Outstanding Youth Research Project of Colleges and Universities in Anhui Province","award":["2024AH030055"],"award-info":[{"award-number":["2024AH030055"]}]},{"name":"the Key Scientific Research Foundation of the Education Department of Province Anhui","award":["2022AH040175"],"award-info":[{"award-number":["2022AH040175"]}]},{"name":"the Anhui Province Clinical Medical Research Translation Special Project","award":["202304295107020006"],"award-info":[{"award-number":["202304295107020006"]}]},{"name":"the Anhui Province Clinical Medical Research Translation Special Project","award":["202304295107020001"],"award-info":[{"award-number":["202304295107020001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05440-x","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:35:30Z","timestamp":1765802130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful VA-ECMO rescue of life-threatening cardiotoxicity following paclitaxel and cisplatin neoadjuvant chemotherapy for laryngeal cancer: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiru","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiancheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"10","key":"5440_CR1","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/biomedicines12102337","volume":"12","author":"A Zotta","year":"2024","unstructured":"Zotta A, Marciano ML, Sabbatino F, et al. Neoadjuvant immunotherapy in head and neck cancers: A paradigm shift in treatment approach. Biomedicines. 2024;12(10):2337.","journal-title":"Biomedicines"},{"issue":"2","key":"5440_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.CCR-23-2398","volume":"30","author":"X Ou","year":"2024","unstructured":"Ou X, Zhai R, Wei W, et al. Induction Toripalimab and chemotherapy for organ preservation in locally advanced laryngeal and hypopharyngeal cancer: A Single-Arm phase II clinical trial. Clin Cancer Res. 2024;30(2):344\u201355.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"5440_CR3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00405-009-0946-3","volume":"266","author":"A Relic","year":"2009","unstructured":"Relic A, Scheich M, Stapf J, et al. Salvage surgery after induction chemotherapy with paclitaxel\/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas. Eur Arch Otorhinolaryngol. 2009;266(11):1799\u2013805.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5440_CR4","doi-asserted-by":"publisher","first-page":"1353435","DOI":"10.3389\/fimmu.2024.1353435","volume":"15","author":"Q Fang","year":"2024","unstructured":"Fang Q, Li X, Xu P, et al. PD-1 inhibitor combined with Paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal\/laryngeal squamous cell carcinoma: efficacy and survival outcomes. Front Immunol. 2024;15:1353435.","journal-title":"Front Immunol"},{"issue":"4","key":"5440_CR5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.21037\/gs-22-161","volume":"11","author":"W Wang","year":"2022","unstructured":"Wang W, Wang L, Chang JY, et al. Cardiotoxicity monitoring of Pyrotinib in combination with nab-paclitaxel, doxorubicin, and cyclophosphamide in HER2-positive breast cancer: a single-armed clinical trial. Gland Surg. 2022;11(4):742\u201350.","journal-title":"Gland Surg"},{"key":"5440_CR6","doi-asserted-by":"publisher","unstructured":"Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf. 2000;22(4):263\u2013302. https:\/\/doi.org\/10.2165\/00002018-200022040-00002.","DOI":"10.2165\/00002018-200022040-00002"},{"issue":"4","key":"5440_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000471759","volume":"12","author":"M Osman","year":"2017","unstructured":"Osman M, Elkady M. A prospective study to evaluate the effect of Paclitaxel on cardiac ejection fraction. Breast Care (Basel). 2017;12(4):255\u20139.","journal-title":"Breast Care (Basel)"},{"issue":"2","key":"5440_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/1097-0142(19880715)62:2<266::AID-CNCR2820620207>3.0.CO;2-Y","volume":"62","author":"AA Jakubowski","year":"1988","unstructured":"Jakubowski AA, Kemeny N. Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer. 1988;62(2):266\u20139.","journal-title":"Cancer"},{"issue":"5","key":"5440_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","volume":"130","author":"A Dolci","year":"2008","unstructured":"Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008;130(5):688\u201395.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"5440_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P, Rokyta R, Karasek J, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023;147(6):454\u201364.","journal-title":"Circulation"},{"issue":"10410","key":"5440_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","volume":"402","author":"U Zeymer","year":"2023","unstructured":"Zeymer U, Freund A, Hochadel M, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials. Lancet. 2023;402(10410):1338\u201346.","journal-title":"Lancet"},{"issue":"13","key":"5440_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2022.01.032","volume":"79","author":"EW Grandin","year":"2022","unstructured":"Grandin EW, Nunez JI, Willar B, et al. Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation. J Am Coll Cardiol. 2022;79(13):1239\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5440_CR13","first-page":"73","volume":"9","author":"R Fisher","year":"2025","unstructured":"Fisher R, Minaya SB, Brunette H, Nogar J, Sud P. Interfacility transfer for VA-ECMO in beta blocker and calcium channel blocker overdoses: A report of two cases. Clin Pract Cases Emerg Med. 2025;9(1):73\u20137.","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"5","key":"5440_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MAT.0000000000002129","volume":"70","author":"D Finn","year":"2024","unstructured":"Finn D, Stevens J, Tolkacz M, Robinson J, Mangla J, Iacco A. Calcium channel blocker overdose: what role does extracorporeal membrane oxygenation have in support? A systematic review of the literature. Asaio J. 2024;70(5):404\u20138.","journal-title":"Asaio J"},{"issue":"5","key":"5440_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/15563650.2020.1870123","volume":"59","author":"A Wong","year":"2021","unstructured":"Wong A, Hoffman RS, Walsh SJ, et al. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2021;59(5):361\u201375.","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"5440_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jaccao.2019.07.004","volume":"1","author":"O Itzhaki Ben Zadok","year":"2019","unstructured":"Itzhaki Ben Zadok O, Ben-Avraham B, Nohria A, et al. Immune-Checkpoint Inhibitor-Induced fulminant myocarditis and cardiogenic shock. JACC CardioOncol. 2019;1(1):141\u20134.","journal-title":"JACC CardioOncol"},{"issue":"5","key":"5440_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1536\/ihj.20-162","volume":"61","author":"H Matsui","year":"2020","unstructured":"Matsui H, Kawai T, Sato Y, et al. A fatal case of myocarditis following myositis induced by pembrolizumab treatment for metastatic upper urinary tract urothelial carcinoma. Int Heart J. 2020;61(5):1070\u20134.","journal-title":"Int Heart J"},{"issue":"5","key":"5440_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaccao.2022.08.013","volume":"4","author":"T Ramayya","year":"2022","unstructured":"Ramayya T, Mitchell JD, Hartupee JC, et al. Delayed diagnosis and recovery of fulminant immune checkpoint Inhibitor-Associated myocarditis on VA-ECMO support. JACC CardioOncol. 2022;4(5):722\u20136.","journal-title":"JACC CardioOncol"},{"issue":"5","key":"5440_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s11427-023-2421-0","volume":"67","author":"CMAWG Cardiology","year":"2024","unstructured":"Chinese Society of, Cardiology CMAWG, Jiang J, Shu H, et al. Chinese society of cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci. 2024;67(5):913\u201339.","journal-title":"Sci China Life Sci"},{"issue":"48","key":"5440_CR20","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1093\/eurheartj\/ehad707","volume":"44","author":"F Huang","year":"2023","unstructured":"Huang F, Ammirati E, Ponnaiah M, et al. Fulminant myocarditis proven by early biopsy and outcomes. Eur Heart J. 2023;44(48):5110\u201324.","journal-title":"Eur Heart J"},{"issue":"5","key":"5440_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/joa3.12751","volume":"38","author":"T Itoh","year":"2022","unstructured":"Itoh T, Kobayashi T, Oshikiri Y, Arakawa Y, Satoh M, Morino Y. Clinical and electrocardiographic characteristics in patients with fulminant myocarditis. J Arrhythm. 2022;38(5):763\u201371.","journal-title":"J Arrhythm"},{"issue":"3","key":"5440_CR22","doi-asserted-by":"publisher","first-page":"e12726","DOI":"10.1111\/anec.12726","volume":"25","author":"C Butta","year":"2020","unstructured":"Butta C, Zappia L, Laterra G, Roberto M. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review. Ann Noninvasive Electrocardiol. 2020;25(3):e12726.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"40","key":"5440_CR23","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46(40):3952\u20134041.","journal-title":"Eur Heart J"},{"issue":"8","key":"5440_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10157-024-02490-x","volume":"28","author":"CA Oliveira","year":"2024","unstructured":"Oliveira CA, Merces EAB, Portela FS, et al. An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management. Clin Exp Nephrol. 2024;28(8):711\u201327.","journal-title":"Clin Exp Nephrol"},{"issue":"22","key":"5440_CR25","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/eurheartj\/ehy077","volume":"39","author":"JR Ghadri","year":"2018","unstructured":"Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (Part II): diagnostic Workup, Outcome, and management. Eur Heart J. 2018;39(22):2047\u201362.","journal-title":"Eur Heart J"},{"issue":"48","key":"5440_CR26","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1093\/eurheartj\/ehad489","volume":"44","author":"HP Schultheiss","year":"2023","unstructured":"Schultheiss HP, Escher F. Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome. Eur Heart J. 2023;44(48):5125\u20137.","journal-title":"Eur Heart J"},{"issue":"1","key":"5440_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bcpt.13804","volume":"132","author":"S Voicu","year":"2023","unstructured":"Voicu S, M\u2019Rad A, Malissin I, Deye N, M\u00e9garbane B. Extracorporeal life support in cardiotoxicant poisoning-A narrative review. Basic Clin Pharmacol Toxicol. 2023;132(1):5\u201320.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5440_CR28","doi-asserted-by":"publisher","unstructured":"Slamowitz A, Sweberg T, Labgold K, Nickerson T. Extracorporeal membrane oxygenation for calcium channel blocker intoxication: a multicenter retrospective registry review. ASAIO J. Published online October 31, 2025. https:\/\/doi.org\/10.1097\/MAT.0000000000002593.","DOI":"10.1097\/MAT.0000000000002593"},{"issue":"4","key":"5440_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/s-0043-1764160","volume":"72","author":"S Maier","year":"2024","unstructured":"Maier S, R\u00f6sner L, Saemann L, et al. Extracorporeal membrane oxygenation in intoxication and overdoses: A systematic review. Thorac Cardiovasc Surg. 2024;72(4):288\u201395.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"5440_CR30","doi-asserted-by":"publisher","first-page":"e255646","DOI":"10.1136\/bcr-2023-255646","volume":"17","author":"D Johnson","year":"2024","unstructured":"Johnson D, Weisleder H, Yuan H, Carrozzi G. Paclitaxel-induced myocarditis presenting as new-onset heart failure. BMJ Case Rep. 2024;17(1):e255646.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"5440_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12471-021-01655-7","volume":"30","author":"TE Osinga","year":"2022","unstructured":"Osinga TE, Oosting SF, van der Meer P, et al. Immune checkpoint inhibitor-associated myocarditis: case reports and a review of the literature. Neth Heart J. 2022;30(6):295\u2013301.","journal-title":"Neth Heart J"},{"issue":"3","key":"5440_CR32","first-page":"472","volume":"12","author":"D Wang","year":"2023","unstructured":"Wang D, Bauersachs J, Berliner D. Immune checkpoint inhibitor associated myocarditis and cardiomyopathy: A translational review. Biology (Basel). 2023;12(3):472.","journal-title":"Biology (Basel)"},{"issue":"2","key":"5440_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.14503\/THIJ-15-5100","volume":"43","author":"AR Amraotkar","year":"2016","unstructured":"Amraotkar AR, Pachika A, Grubb KJ, DeFilippis AP. Rapid extracorporeal membrane oxygenation overcomes fulminant myocarditis induced by 5\u2013Fluorouracil. Tex Heart Inst J. 2016;43(2):178\u201382.","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"5440_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/1995-705X.132144","volume":"15","author":"R Hollriegel","year":"2014","unstructured":"Hollriegel R, Fischer J, Schuler G. Early extracorporeal membrane oxygenation support for 5-Fluorouracil-induced acute heart failure with cardiogenic shock. Heart Views. 2014;15(1):26\u20138.","journal-title":"Heart Views"},{"issue":"12","key":"5440_CR35","first-page":"1","volume":"7","author":"L Vanoverbeke","year":"2023","unstructured":"Vanoverbeke L, Wouter H, Francois D, Ivan E. Cardiogenic shock after 5-fluorouracil administration: a case report and literature review. Eur Heart J Case Rep. 2023;7(12):1\u20136.","journal-title":"Eur Heart J Case Rep"},{"issue":"4","key":"5440_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2459\/JCM.0b013e32832e934b","volume":"11","author":"JD Bathina","year":"2010","unstructured":"Bathina JD, Yusuf SW. 5-Fluorouracil-induced coronary vasospasm. J Cardiovasc Med (Hagerstown). 2010;11(4):281\u20134.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"Suppl 1","key":"5440_CR37","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.2459\/JCM.0000000000000376","volume":"17","author":"C Madeddu","year":"2016","unstructured":"Madeddu C, Deidda M, Piras A, et al. Pathophysiology of cardiotoxicity induced by Nonanthracycline chemotherapy. J Cardiovasc Med (Hagerstown). 2016;17(Suppl 1):e12\u20138.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"41","key":"5440_CR38","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, Lopez-Fernandez T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"9","key":"5440_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00277-002-0534-8","volume":"81","author":"X Thomas","year":"2002","unstructured":"Thomas X, Le QH, Fiere D. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol. 2002;81(9):504\u20137.","journal-title":"Ann Hematol"},{"key":"5440_CR40","doi-asserted-by":"publisher","first-page":"713694","DOI":"10.3389\/fcvm.2021.713694","volume":"8","author":"A Montisci","year":"2021","unstructured":"Montisci A, Palmieri V, Liu JE, et al. Severe cardiac toxicity induced by cancer therapies requiring intensive care unit admission. Front Cardiovasc Med. 2021;8:713694.","journal-title":"Front Cardiovasc Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05440-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05440-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05440-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:26:59Z","timestamp":1768915619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05440-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5440"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05440-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted under ethical principles (Declaration of Helsinki). Written consent was obtained from each patient or her authorized representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and coinsent to participate"}},{"value":"Written informed consent was obtained from the patient for all the manuscripts that included images and details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}